Flagship Ventures Fund V General Partner is based out of Cambridge. Whalewisdom has at least 8 Form 4 filings
2024-06-30
Top Buys (13F)
| Name | % Change |
|---|
2024-06-30
Top Sells (13F)
| Name | % Change |
|---|
2024-06-30
13F Holdings Summary
| Name | $ Change |
|---|---|
| FHTX Foghorn Therapeutics | 45.56% |
| SANA Sana Biotechnology I | 42.16% |
| OMGA Omega Therapeutics I | 12.28% |
All or part of FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC 13F disclosures were filed
under a combined 13F through
FLAGSHIP PIONEERING INC.
for 2024-06-30
for 2024-06-30
2024-06-30
13F Activity
| Market Value | $118m, Prior: $207m |
| New Purchases | 0 stocks |
| Added To | 0 stocks |
| Sold out of | 0 stocks |
| Reduced holdings in | 0 stocks |
| Top 10 Holdings % | 100% |
| Turnover %[1] | 0% |
| Turnover Alt %[2] | 0% |
| Time Held Top 20 | 5 quarters |
| Time Held Top 10 | 5 quarters |
| Time Held All | 5 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2024-06-30
13F Sector Allocation Over Time
limited to past 4 quarters. Subscribe to see all available data
2024-06-30
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2024-06-30